Health Condition 1: O722- Delayed and secondary postpartum hemorrhage
Conditions
Interventions
Intervention1: tranexamic acid: ACTIVE INTERVENTION
Inj TRANEXEMIC ACID 1 GRAM DILUTED IN 100 ML RL IV, ALONG WITH OXYTOCIN 10 UNIT IM
Intervention2: Tranexamic
Acid: Not applicable
Intervention3: T
Sponsors
Dr Surekha Atul Tayade
Eligibility
Inclusion criteria
Inclusion criteria: Scheduled or unscheduled vaginal delivery of all age groups and parity Singleton or twin gestation
Exclusion criteria
Exclusion criteria: Severe medical and surgical complications History of allergy to tranexamic acid History of thrombi-embolic disorders. Antenatal complications like, abnormal placenta Placenta-previa, placenta abruption, adherent placenta, severe preeclampsia, Multiple pregnancies, macrosomia, polyhydramnios, Fibroid uterus or gynaecological disorders complicating pregnancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference in blood loss between the two groups : In women receiving tranexamic acid In women receiving placebo Timepoint: OUTCOME WILL BE ASSESSED AT THE END OF 2 YEARS | — |
Secondary
| Measure | Time frame |
|---|---|
| To determine need for blood transfusion. To determine need for additional uterotonics Timepoint: THE OUTCOMES WILL BE ASSESSED AT THE END OF 2 YEARS | — |
Countries
India
Contacts
Public ContactSukanya Singh
JAWAHARLAL NEHRU MEDICAL COLLEGE
Outcome results
None listed